Ontology highlight
ABSTRACT:
INSTRUMENT(S): Q Exactive
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Cell Culture
SUBMITTER: Alexander Schmidt
LAB HEAD: Alexander Schmidt
PROVIDER: PXD013159 | Pride | 2020-01-13
REPOSITORIES: Pride
Action | DRS | |||
---|---|---|---|---|
001_HSK-Ub1_180703225807_C18.raw | Raw | |||
001_HSK-Ub1_C18.raw | Raw | |||
002_HSK-Ub1_180704192956_C18.raw | Raw | |||
002_HSK-Ub1_C18.raw | Raw | |||
003_HSK-Ub1_C18.raw | Raw |
Items per page: 5 1 - 5 of 17 |
Tang Fengyuan F Gao Ruize R Jeevan-Raj Beena B Wyss Christof B CB Kalathur Ravi K R RKR Piscuoglio Salvatore S Ng Charlotte K Y CKY Hindupur Sravanth K SK Nuciforo Sandro S Dazert Eva E Bock Thomas T Song Shuang S Buechel David D Morini Marco F MF Hergovich Alexander A Matthias Patrick P Lim Dae-Sik DS Terracciano Luigi M LM Heim Markus H MH Hall Michael N MN Christofori Gerhard G
Nature communications 20191217 1
Autophagy perturbation represents an emerging therapeutic strategy in cancer. Although LATS1 and LATS2 kinases, core components of the mammalian Hippo pathway, have been shown to exert tumor suppressive activities, here we report a pro-survival role of LATS1 but not LATS2 in hepatocellular carcinoma (HCC) cells. Specifically, LATS1 restricts lethal autophagy in HCC cells induced by sorafenib, the standard of care for advanced HCC patients. Notably, autophagy regulation by LATS1 is independent of ...[more]